James M. Inhofe sold CRSP

June 19, 2018 · STOCK Act disclosure

Senator James M. Inhofe (Republican-OK) sold CRISPR Therapeutics AG, a stock transaction, valued at $15,001 - $50,000. The trade took place on June 19, 2018 and was disclosed on June 20, 2018 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.

Type

Sell

Amount

$15,001 - $50,000

Transaction date

June 19, 2018

Disclosed

June 20, 2018

MemberJames M. Inhofe

ChamberSenate

Party / StateRepublican · OK

AssetCRISPR Therapeutics AG (CRSP)

Security typeStock

OwnerSelf

Amount range$15,001 - $50,000

Transaction dateJune 19, 2018

Filing dateJune 20, 2018

AmendmentNo

Asset description

CRISPR Therapeutics AG

View the original STOCK Act disclosure